This HTML5 document contains 145 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n11http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n13https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q44616007
rdf:type
wikibase:Item
schema:description
artículu científicu научна статия 2013年学术文章 artikulong pang-agham vedecký článok 2013年学术文章 bài báo khoa học სამეცნიერო სტატია tudományos cikk 2013 nî lūn-bûn artikel ilmiah مقالة علمية نشرت في 18 يوليو 2013 2013年學術文章 vitenskapelig artikkel article scientifique scientific article published on 18 July 2013 2013年學術文章 2013年学术文章 naučni članak bilimsel makale научная статья scientific article published on 18 July 2013 articolo scientifico 2013年學術文章 επιστημονικό άρθρο artigo científico scienca artikolo мақолаи илмӣ 2013年学术文章 наукова стаття, опублікована в липні 2013 artykuł naukowy บทความทางวิทยาศาสตร์ artigo científico wetenschappelijk artikel vitskapeleg artikkel научни чланак 2013年學術文章 ১৮ জুলাই ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2013年学术文章 2013년 논문 article científic wissenschaftlicher Artikel artikull shkencor scientific article published on 18 July 2013 vetenskaplig artikel vědecký článek 2013年学术文章 artículo científico publicado en 2013 article scientific teaduslik artikkel videnskabelig artikel 2013年學術文章 научни чланак artigo científico 2013年の論文 מאמר מדעי tieteellinen artikkeli articol științific
p:P577
wds:Q44616007-B0180F3B-68C9-433D-BB1F-476FDE36979B
wdt:P577
2013-07-18T00:00:00Z
p:P2888
wds:Q44616007-6BE21A64-2296-4A1E-8B2B-70B89DF4439E
wdt:P2888
n13:s00520-013-1891-7
p:P2860
wds:Q44616007-949E41FF-A732-41E6-B986-4DF9158418CF wds:Q44616007-F958D4DE-CABB-47CE-B856-E81374C4D0C8 wds:Q44616007-D1D277A5-1E3D-4BB3-A294-CB8669C8B042 wds:Q44616007-E6C9EEAC-737B-4960-8FB4-EEC99364FE3A wds:Q44616007-20840802-BC56-4D19-B27F-E7B0B475D5FB wds:Q44616007-28285540-4296-42F3-A0A5-34D3540DD734 wds:Q44616007-13306441-2432-49B3-A56D-43EA27C181A6 wds:Q44616007-18D79CD5-1147-4EF0-BB0B-9F03F72E7E9E wds:Q44616007-1E55BC0C-4ADA-480B-BC9F-737A86F87129 wds:Q44616007-3637EA3B-C550-4A77-89D7-597AB5FF495A wds:Q44616007-43A839F7-FC51-43B1-9D33-BA9C85562589 wds:Q44616007-5AE529F7-9916-4279-9BE7-0279F7C9C160 wds:Q44616007-339830B8-21E3-4BC8-A2FA-E1DA03C469DE wds:Q44616007-3463D83C-722F-467C-9F39-CFC49002CFE8 wds:Q44616007-78F074D6-C89C-4678-BA60-C298BD7B7130 wds:Q44616007-8347F65E-A4A0-421E-BE56-796E6A2AF514 wds:Q44616007-86AD88C9-4596-42D3-8F87-15C7BD43DD1A wds:Q44616007-A3721173-F0DE-42ED-A643-DB21DDF83113 wds:Q44616007-B24051BE-0B80-47EE-BC41-1D06265C5F36 wds:Q44616007-C05AA30F-7868-4359-B882-F5C764441A99 wds:Q44616007-902FF6A0-A8FB-4E40-84D2-44650CD8A7B3
wdt:P2860
wd:Q34247522 wd:Q83483437 wd:Q40813165 wd:Q77530575 wd:Q38505465 wd:Q35075214 wd:Q37016543 wd:Q48657549 wd:Q33865929 wd:Q33819306 wd:Q48677815 wd:Q36818341 wd:Q57194272 wd:Q51022685 wd:Q36671063 wd:Q47579629 wd:Q44761558 wd:Q35652429 wd:Q37723328 wd:Q29540774 wd:Q53514340
p:P2093
wds:Q44616007-11C82A6D-46F8-4A9D-B6BC-0859FF8D6A9F wds:Q44616007-618EC5A2-9F0D-4AE5-BA83-474FEAE87D27 wds:Q44616007-0B680EE7-1E63-4126-8B98-D70309250D7F wds:Q44616007-8FD71BB1-C019-4A60-B315-BF49F2EE29F6
wdt:P2093
Karin Nordin Mats Hansson Ulrik Kihlbom Peter Nygren
rdfs:label
Phase 1 clinical trials in end-stage cancer: patient understanding of trial premises and motives for participation. Phase 1 clinical trials in end-stage cancer: patient understanding of trial premises and motives for participation.
skos:prefLabel
Phase 1 clinical trials in end-stage cancer: patient understanding of trial premises and motives for participation. Phase 1 clinical trials in end-stage cancer: patient understanding of trial premises and motives for participation.
schema:name
Phase 1 clinical trials in end-stage cancer: patient understanding of trial premises and motives for participation. Phase 1 clinical trials in end-stage cancer: patient understanding of trial premises and motives for participation.
p:P50
wds:Q44616007-8C4DB1EE-F715-4A78-8DE6-FAB6F248D721
wdt:P50
wd:Q59159269
p:P1476
wds:Q44616007-351491FB-0E89-4CC1-BC7E-805E41DFBFF5
wdt:P1476
Phase 1 clinical trials in end-stage cancer: patient understanding of trial premises and motives for participation
p:P304
wds:Q44616007-7207F7FD-09F6-42CF-A929-8C7F67C65DE6
wdt:P304
3137-3142
p:P31
wds:Q44616007-78842AA3-00B1-4DE4-8CB1-94B6900D913B
wdt:P31
wd:Q13442814
p:P921
wds:Q44616007-28B87505-69C3-402B-90EF-9725CB978823 wds:Q44616007-989FCA3F-22D5-448A-8726-D5398FB11792
wdt:P921
wd:Q181600 wd:Q5452194
p:P698
wds:Q44616007-CB530D42-3238-46E7-8D41-0302C7A8A230
wdtn:P698
n12:23864288
wdt:P698
23864288
p:P1433
wds:Q44616007-2B6A3E84-40A2-4A97-88FA-50149423146A
wdt:P1433
wd:Q15766919
p:P433
wds:Q44616007-2E55AC10-56BC-45D1-9251-AACE5C9053F6
p:P478
wds:Q44616007-6C8EAF1D-5A33-4889-84E5-62E74C48E66D
wdt:P433
11
wdt:P478
21
p:P356
wds:Q44616007-DEE99681-5983-4CA9-ABBB-4B38F6304557
wdtn:P356
n11:S00520-013-1891-7
wdt:P356
10.1007/S00520-013-1891-7
p:P5875
wds:Q44616007-EF512C01-4C8E-4AD7-A487-43F7724948A2
wdt:P5875
249997667